Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
NCT02649075 is registered in ClinicalTrials.gov with Entera Health, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
- Lead sponsor
- Entera Health, Inc
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 29, 2016
- Completion date
- August 31, 2017
- Enrollment
- 7 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease